Skip to main content
Log in

Non invasive in vivo study of the maturation of CYP IIIA in neonates and infants

  • PHARMACOKINETICS AND DISPOSITION
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Objective: Cytochrome P450 III (CYP III) has previously been demonstrated in vitro in fetal liver.

Methods:

A study was performed in 7 premature, 13 term neonates and 30 infants to assess whether or not maturation had any influence on CYP IIIA activity in children from birth to 1 year of age. A simple non invasive procedure was used (6 βOHF/FF concentration ratio in a morning spot urine sample).

Results:

The 6 βOHF/FF ratio was 7.2, 7.9 and 5.0 in premature and term neonates and infants, respectively. CYP IIIA activity is present at birth, with a 6 βOHF/FF ratio comparable to adults. Its activity seemed lower in infants. This might be due to the decrease in CYP IIIA7 activity during maturation after birth, which might be more rapid than the increase in CYP IIIA3/4 activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: 1 August 1995/ Accepted in revised form: 23 February 1996

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vauzelle-Kervroedan, F., Rey, E., Pariente-Khayat, A. et al. Non invasive in vivo study of the maturation of CYP IIIA in neonates and infants. E J Clin Pharmacol 51, 69–72 (1996). https://doi.org/10.1007/s002280050162

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002280050162

Navigation